• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭住院后早期导管消融治疗心房颤动的疗效。

Efficacy of Early Catheter Ablation for Atrial Fibrillation After Admission for Heart Failure.

机构信息

Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan; Center for Clinical and Translational Research of Kyushu University Hospital, Fukuoka, Japan.

出版信息

JACC Clin Electrophysiol. 2023 Sep;9(9):1948-1959. doi: 10.1016/j.jacep.2023.05.038. Epub 2023 Jul 19.

DOI:10.1016/j.jacep.2023.05.038
PMID:37480855
Abstract

BACKGROUND

Advances in catheter ablation (CA) for atrial fibrillation (AF) have improved the prognosis of patients with heart failure (HF) and AF. However, its optimal timing remains to be fully elucidated.

OBJECTIVES

The aim of this study was to investigate the prognostic impact of early CA in patients with HF and AF hospitalized for worsening HF.

METHODS

From JROADHF (Japanese Registry of Acute Decompensated Heart Failure) (n = 13,238), patients with HF and AF who underwent CA within 90 days after admission for HF (early CA; n = 103) and those who did not (control; n = 2,683) were identified. Mortality was compared between these groups in the crude cohort, as well as in the propensity-matched cohort (n = 83 in each group).

RESULTS

In the crude cohort, all-cause mortality was significantly lower in the early CA group than in the control group (log-rank P < 0.001; HR: 0.38; 95% CI: 0.24-0.60). In the matched cohort, all-cause mortality was likewise significantly lower in the early CA group (log-rank P = 0.014; HR: 0.47; 95% CI: 0.25-0.88). Cardiovascular death and HF mortality were significantly lower in both cohorts (crude: Gray' test: P < 0.001 and P = 0.005; subdistribution HR: 0.28 [95% CI: 0.13-0.63] and HR: 0.31 [95% CI: 0.13-0.75]; matched: Gray's test: P = 0.006 and P = 0.017; subdistribution HR: 0.24 [95% CI: 0.08-0.70] and HR: 0.28 [95% CI: 0.09-0.84], respectively).

CONCLUSIONS

In a nationwide representative real-world cohort, CA for AF within 90 days after admission for HF was associated with improved long-term outcomes, including cardiovascular and HF death in patients with HF and AF.

摘要

背景

心房颤动(AF)的导管消融术(CA)的进步改善了心力衰竭(HF)和 AF 患者的预后。然而,其最佳时机仍有待充分阐明。

目的

本研究旨在探讨 HF 恶化住院患者早期 CA 对 HF 合并 AF 患者的预后影响。

方法

从 JROADHF(日本急性失代偿性心力衰竭登记研究)(n=13238)中,确定了在 HF 入院后 90 天内接受 CA(早期 CA;n=103)和未接受 CA(对照组;n=2683)的 HF 合并 AF 患者。在未校正队列以及倾向匹配队列(每组 83 例)中比较两组间的死亡率。

结果

在未校正队列中,早期 CA 组的全因死亡率明显低于对照组(log-rank P<0.001;HR:0.38;95%CI:0.24-0.60)。在匹配队列中,早期 CA 组的全因死亡率也明显较低(log-rank P=0.014;HR:0.47;95%CI:0.25-0.88)。两个队列的心血管死亡和 HF 死亡率均显著降低(未校正:Gray 检验:P<0.001 和 P=0.005;亚分布 HR:0.28 [95%CI:0.13-0.63] 和 HR:0.31 [95%CI:0.13-0.75];匹配:Gray 检验:P=0.006 和 P=0.017;亚分布 HR:0.24 [95%CI:0.08-0.70] 和 HR:0.28 [95%CI:0.09-0.84])。

结论

在全国代表性的真实世界队列中,HF 入院后 90 天内进行 AF 的 CA 与 HF 合并 AF 患者的长期预后改善相关,包括心血管和 HF 死亡。

相似文献

1
Efficacy of Early Catheter Ablation for Atrial Fibrillation After Admission for Heart Failure.心力衰竭住院后早期导管消融治疗心房颤动的疗效。
JACC Clin Electrophysiol. 2023 Sep;9(9):1948-1959. doi: 10.1016/j.jacep.2023.05.038. Epub 2023 Jul 19.
2
Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry.心房颤动合并心力衰竭患者的导管消融术:来自瑞典心力衰竭登记处的见解
Eur J Heart Fail. 2022 Sep;24(9):1636-1646. doi: 10.1002/ejhf.2604. Epub 2022 Jul 20.
3
Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study.房颤伴射血分数降低和保留的心衰患者的导管消融治疗:来自 KiCS-AF 多中心队列研究的见解。
Europace. 2023 Feb 8;25(1):83-91. doi: 10.1093/europace/euac108.
4
Atrial fibrillation type and long-term clinical outcomes in hospitalized patients with heart failure: insight from JROADHF.住院心力衰竭患者的心房颤动类型与长期临床结局:来自 JROADHF 的观察。
Eur Heart J Qual Care Clin Outcomes. 2024 May 22;10(3):193-202. doi: 10.1093/ehjqcco/qcae005.
5
Atrial Fibrillation Ablation Outcomes and Heart Failure (from the Kansai Plus Atrial Fibrillation Registry).心房颤动消融结果与心力衰竭(来自关西加心房颤动注册研究)
Am J Cardiol. 2023 Feb 15;189:108-118. doi: 10.1016/j.amjcard.2022.11.038. Epub 2022 Dec 14.
6
Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation.导管消融与心房颤动导致的死亡率、中风及心力衰竭再入院情况。
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001369.
7
Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart disease.首次诊断房颤与导管消融之间时间间隔的增加,对合并或不合并结构性心脏病患者的长期预后均产生不利影响。
J Cardiovasc Electrophysiol. 2023 Mar;34(3):507-515. doi: 10.1111/jce.15810. Epub 2023 Jan 22.
8
Major adverse cardiovascular events and mortality after catheter ablation in Japanese patients with atrial fibrillation: The Fushimi AF Registry.日本心房颤动患者导管消融后的主要不良心血管事件和死亡率:伏见 AF 登记研究。
Heart Vessels. 2021 Aug;36(8):1219-1227. doi: 10.1007/s00380-021-01796-0. Epub 2021 Feb 11.
9
Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure.心力衰竭的真实世界心房颤动患者中导管消融降低死亡率。
Sci Rep. 2021 Feb 25;11(1):4694. doi: 10.1038/s41598-021-84256-z.
10
One year outcomes of atrial fibrillation ablation: Contemporary analysis of the United States Nationwide Readmission Database.心房颤动消融术的一年预后:美国全国再入院数据库的当代分析。
Pacing Clin Electrophysiol. 2022 Sep;45(9):1151-1159. doi: 10.1111/pace.14543. Epub 2022 Jun 10.

引用本文的文献

1
Pre-Clinical Models of Heart Failure with Preserved Ejection Fraction: Advancing Knowledge for Device Based Therapies.射血分数保留的心力衰竭的临床前模型:推进基于器械治疗的知识
Ann Biomed Eng. 2025 Aug 25. doi: 10.1007/s10439-025-03821-z.
2
Association between cardiometabolic comorbidity and mortality in patients with atrial fibrillation.心房颤动患者心脏代谢合并症与死亡率之间的关联。
BMC Cardiovasc Disord. 2025 Apr 30;25(1):344. doi: 10.1186/s12872-025-04784-8.
3
Atrial Fibrillation Ablation: Impact on Burden and Cardiovascular Outcomes.
心房颤动消融术:对负担和心血管结局的影响。
J Clin Med. 2025 Apr 12;14(8):2648. doi: 10.3390/jcm14082648.
4
Early catheter ablation: A promising and effective approach for atrial fibrillation and post-heart failure recovery-Timing matters.早期导管消融:一种用于心房颤动和心力衰竭后恢复的有前景且有效的方法——时机很重要。
Int J Cardiol Heart Vasc. 2025 Jan 9;56:101604. doi: 10.1016/j.ijcha.2025.101604. eCollection 2025 Feb.
5
Catheter ablation for persistent atrial fibrillation after acute decompensated heart failure Attack: Earlier is Better?急性失代偿性心力衰竭发作后持续性心房颤动的导管消融:越早越好?
Int J Cardiol Heart Vasc. 2024 Dec 28;56:101589. doi: 10.1016/j.ijcha.2024.101589. eCollection 2025 Feb.
6
Clinical Outcomes of Catheter Ablation for Atrial Fibrillation in Patients with Acute Decompensated Heart Failure.急性失代偿性心力衰竭患者房颤导管消融的临床结局
J Clin Med. 2025 Jan 19;14(2):629. doi: 10.3390/jcm14020629.
7
Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry.心房颤动诊断至消融时间对冷冻球囊全球注册研究中24个月疗效和安全性结局的影响。
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf008.
8
Early Cryoablation After First Diagnosis of Atrial Fibrillation Reduces Arrhythmia Recurrence in Heart Failure Patients.心房颤动首次诊断后早期冷冻消融可降低心力衰竭患者心律失常复发率。
JACC Asia. 2024 Sep 24;4(11):857-871. doi: 10.1016/j.jacasi.2024.08.005. eCollection 2024 Nov.
9
Atrial Fibrillation Ablation During Hospitalization for Acute Heart Failure: Feasibility and Role of Pulsed Field Ablation.急性心力衰竭住院期间的心房颤动消融:脉冲场消融的可行性及作用
J Cardiovasc Electrophysiol. 2025 Jan;36(1):256-265. doi: 10.1111/jce.16507. Epub 2024 Nov 26.
10
Heart Failure-Related Death in Subjects With Atrial Fibrillation in the United States, 1999 to 2020.美国 1999 年至 2020 年房颤患者的心力衰竭相关性死亡。
J Am Heart Assoc. 2024 May 7;13(9):e033897. doi: 10.1161/JAHA.123.033897. Epub 2024 Apr 30.